Categories announced for the 2024 Digiday Technology Awards

Older messages

With 'Charlie,' Pfizer is building a new generative AI platform for pharma marketing

Thursday, February 22, 2024

Pfizer has developed its own generative AI platform called “Charlie,” named after Pfizer co-founder Charles Pfizer. February 22, 2024 With 'Charlie,' Pfizer is building a new generative AI

Connect one-on-one with programmatic marketing leaders

Wednesday, February 21, 2024

Secure months' worth of meetings over just three days ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The state of publisher revenue

Wednesday, February 21, 2024

The rise of total revenue optimization in 2024 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Atlas Obscura looks to raise $10 million at a $24 million valuation with help from smaller investors in a tough market

Wednesday, February 21, 2024

Atlas Obscura is in the process of raising $10 million in an investment round that includes 20 returning investors – and for the first time, smaller investors participating through the venture capital

Amazon wants a bigger slice of the DSP ad tech market

Tuesday, February 20, 2024

Over the last year or so, ad execs have noted how much Amazon's ad tech has changed to become omnichannel in nature — ie more of a competitor to the two largest DSPs: The Trade Desk and

You Might Also Like

🚨 We’re Going LIVE! 🚨Ask Me Anything B2B Marketing is Starting

Monday, September 16, 2024

Here Is The Link To Join! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🎙️ Free Webinar Tomorrow: Get Expert B2B Marketing Advice

Monday, September 16, 2024

🚨 Free Webinar Tomorrow! Last Chance To RSVP! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The $200/day Facebook side hustle...

Monday, September 16, 2024

A couple years ago, I never would have thought I'd be making money directly on Facebook, through the performance bonus program. However, at the beginning of this month, I've been making nearly

SEC Drops Term ‘Crypto Asset Securities’ in Binance Case

Monday, September 16, 2024

September 16, 2024 | Read Online SEC Drops Term 'Crypto Asset Securities' in Binance Case Plus Markets Price in Jumbo 50bps Rate Cut for Fed Meeting fb fb fb fb The Breakdown First Five -

What do you do when your product launch fails? [Roundup]

Monday, September 16, 2024

Hey Reader, If you've sold on Amazon for a while, you'll (inevitably) learn that products get old fast. Either you run out of stock and sales aren't what it used to be or product sales just

What channels move the needle for agencies

Monday, September 16, 2024

How agencies are aligning marketing strategies with consumer behavior ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

All Eyes On The Federal Reserve This Week

Monday, September 16, 2024

Today's letter is brought to you by Domain Money! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Prompting with AI templates

Monday, September 16, 2024

Today's Guide to the Marketing Jungle from Social Media Examiner... Presented by social-media-marketing-world-logo It's National Collect Rocks Day, Reader... Go fill those pockets! In

Behind Mr. Ballen’s true crime kingdom 💀

Monday, September 16, 2024

The man. The myth. And his 8-figure business. Trends logo If you don't love emotional rollercoasters with missing persons, murder mysteries, and macabre intentions on otherwise quiet commutes,

Huntress secures revenue milestone

Monday, September 16, 2024

Mid-market deals spark revival; checking up on healthcare funds; VC dealmaking for India's unicorns stalls Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: